EFFECT OF KETANSERIN ON LIPOPROTEINS IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：5
作者：
ARAKAWA, K
SASAKI, J
SAKU, K
IDEISHI, S
SAEKI, Y
BABA, K
IKEDA, K
KATO, Y
OHBA, H
DOI, H
机构：
[1] FUKUOKA UNIV HOSP, DEPT INTERNAL MED, 7-45-1 JONAN KU, FUKUOKA, JAPAN
[2] NAKABARU HOSP, FUKUOKA, JAPAN
[3] FUKUOKA NATL CENT HOSP, FUKUOKA, JAPAN
[4] WAKASUGI HOSP, FUKUOKA, JAPAN
[5] HAKUJUJI HOSP, FUKUOKA, JAPAN
[6] IIZUKA HOSP, FUKUOKA, JAPAN
[7] SAISEIKAI FUKUOKA GEN HOSP, FUKUOKA, JAPAN
来源：
DRUGS | 1988年 / 36卷
关键词：
D O I：
10.2165/00003495-198800361-00025
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：126 / 129
页数：4
相关论文
共 15 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]  
[Anonymous], 1970, JAMA, V213, P1143
[3]   CHARACTERIZATION OF HUMAN HIGH-DENSITY LIPOPROTEINS BY GRADIENT GEL-ELECTROPHORESIS [J].
BLANCHE, PJ ;
GONG, EL ;
FORTE, TM ;
NICHOLS, AV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (03) :408-419
[4]   EINE NEUE BESTIMMUNG DER NEUTRALFETTE IM BLUTSERUM UND GEWEBE .I. PRINZIP DURCHFUHRUNG UND BESPRECHUNG DER METHODE [J].
EGGSTEIN, M ;
KREUTZ, FH .
KLINISCHE WOCHENSCHRIFT, 1966, 44 (05) :262-&
[5]  
EISENBERG S, 1984, J LIPID RES, V25, P1017
[6]   METABOLIC ASPECTS OF ANTIHYPERTENSIVE TREATMENT WITH KETANSERIN [J].
FERRARA, LA ;
FASANO, ML ;
SORO, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (05) :1007-1008
[7]  
GOTO Y, 1986, J CLIN BIOCHEM NUTR, V1, P73
[8]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[9]   KETANSERIN, A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST - MONOTHERAPY IN ESSENTIAL-HYPERTENSION [J].
HEDNER, T ;
PERSSON, B ;
BERGLUND, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :121-125
[10]   RECEPTOR-BINDING PROFILE OF R-41-468, A NOVEL ANTAGONIST AT 5-HT2 RECEPTORS [J].
LEYSEN, JE ;
AWOUTERS, F ;
KENNIS, L ;
LADURON, PM ;
VANDENBERK, J ;
JANSSEN, PAJ .
LIFE SCIENCES, 1981, 28 (09) :1015-1022
12